These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30508556)

  • 1. Optimization of production of vesicular stomatitis virus (VSV) in suspension serum-free culture medium at high cell density.
    Elahi SM; Shen CF; Gilbert R
    J Biotechnol; 2019 Jan; 289():144-149. PubMed ID: 30508556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells.
    Côté J; Garnier A; Massie B; Kamen A
    Biotechnol Bioeng; 1998 Sep; 59(5):567-75. PubMed ID: 10099373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of suspension adapted Vero cell culture process technology for production of viral vaccines.
    Shen CF; Guilbault C; Li X; Elahi SM; Ansorge S; Kamen A; Gilbert R
    Vaccine; 2019 Nov; 37(47):6996-7002. PubMed ID: 31288997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture.
    Broussau S; Jabbour N; Lachapelle G; Durocher Y; Tom R; Transfiguracion J; Gilbert R; Massie B
    Mol Ther; 2008 Mar; 16(3):500-7. PubMed ID: 18180776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of dextran sulfate in culture media on titration of vesicular stomatitis virus.
    Elahi SM; Shen CF; Gilbert R
    J Virol Methods; 2020 Jan; 275():113758. PubMed ID: 31678047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesiculovirus neutralization by natural IgM and complement.
    Tesfay MZ; Ammayappan A; Federspiel MJ; Barber GN; Stojdl D; Peng KW; Russell SJ
    J Virol; 2014 Jun; 88(11):6148-57. PubMed ID: 24648451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ruxolitinib and Polycation Combination Treatment Overcomes Multiple Mechanisms of Resistance of Pancreatic Cancer Cells to Oncolytic Vesicular Stomatitis Virus.
    Felt SA; Droby GN; Grdzelishvili VZ
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia.
    Betancourt D; Ramos JC; Barber GN
    J Virol; 2015 Dec; 89(23):11786-800. PubMed ID: 26378177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of adenovirus production in serum-free 293SF suspension culture by GFP-expression monitoring.
    Côté J; Bourget L; Garnier A; Kamen A
    Biotechnol Prog; 1997; 13(6):709-14. PubMed ID: 9413130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some attenuated variants of vesicular stomatitis virus show enhanced oncolytic activity against human glioblastoma cells relative to normal brain cells.
    Wollmann G; Rogulin V; Simon I; Rose JK; van den Pol AN
    J Virol; 2010 Feb; 84(3):1563-73. PubMed ID: 19906910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer.
    Yu N; Puckett S; Antinozzi PA; Cramer SD; Lyles DS
    J Virol; 2015 May; 89(10):5250-63. PubMed ID: 25741004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early steps of the virus replication cycle are inhibited in prostate cancer cells resistant to oncolytic vesicular stomatitis virus.
    Carey BL; Ahmed M; Puckett S; Lyles DS
    J Virol; 2008 Dec; 82(24):12104-15. PubMed ID: 18829743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Packaging cells for lentiviral vectors generated using the cumate and coumermycin gene induction systems and nanowell single-cell cloning.
    Broussau S; Lytvyn V; Simoneau M; Guilbault C; Leclerc M; Nazemi-Moghaddam N; Coulombe N; Elahi SM; McComb S; Gilbert R
    Mol Ther Methods Clin Dev; 2023 Jun; 29():40-57. PubMed ID: 36936448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus core protein enhances hepatocellular carcinoma cells to be susceptible to oncolytic vesicular stomatitis virus through down-regulation of HDAC4.
    Moon J; Kaowinn S; Cho IR; Min DS; Myung H; Oh S; Kaewpiboon C; Kraemer OH; Chung YH
    Biochem Biophys Res Commun; 2016 Jun; 474(3):428-434. PubMed ID: 27150631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor.
    Ghani K; Garnier A; Coelho H; Transfiguracion J; Trudel P; Kamen A
    Biotechnol Bioeng; 2006 Nov; 95(4):653-60. PubMed ID: 16947907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles.
    Dalton KP; Rose JK
    Virology; 2001 Jan; 279(2):414-21. PubMed ID: 11162797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an infectious surrogate hepatitis C virus based on a recombinant vesicular stomatitis virus expressing hepatitis C virus envelope glycoproteins and green fluorescent protein.
    Okuma K; Fukagawa K; Tateyama S; Kohma T; Mochida K; Hiyoshi M; Takahama Y; Hamaguchi Y; Hirose K; Buonocore L; Rose JK; Mizuochi T; Hamaguchi I
    Jpn J Infect Dis; 2015; 68(3):203-8. PubMed ID: 25672345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein.
    Yang Y; Vanin EF; Whitt MA; Fornerod M; Zwart R; Schneiderman RD; Grosveld G; Nienhuis AW
    Hum Gene Ther; 1995 Sep; 6(9):1203-13. PubMed ID: 8527479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular UDP and P2Y6 function as a danger signal to protect mice from vesicular stomatitis virus infection through an increase in IFN-β production.
    Li R; Tan B; Yan Y; Ma X; Zhang N; Zhang Z; Liu M; Qian M; Du B
    J Immunol; 2014 Nov; 193(9):4515-26. PubMed ID: 25261483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable deficiencies in the interferon response enhance susceptibility to vesicular stomatitis virus oncolytic actions in glioblastoma cells but not in normal human glial cells.
    Wollmann G; Robek MD; van den Pol AN
    J Virol; 2007 Feb; 81(3):1479-91. PubMed ID: 17108037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.